The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?
Zeidner, Joshua F., Zahurak, Marianna, Rosner, Gary L., Gocke, Christopher D., Jones, Richard J., Smith, B. DouglasVolume:
56
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2014.910868
Date:
January, 2015
File:
PDF, 296 KB
english, 2015